Dizal (Jiangsu) Pharmaceutical Co. Ltd. AEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 51.16 CNY | 86,18 CNY | 35,73 CNY |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - CNY | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 465.165.842 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Dizal (Jiangsu) Pharmaceutical Co. Ltd. A
Mitarbeiter 1.009
Handelsplatz SHG
Ticker Symbol 688192
IPO Datum -
Adresse No. 199 and 245 Liangjing Rd, Shanghai, China, 201203
Webseite https://www.dizalpharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Zhang Xiaolin Ph.D. | GM & Chairman |
| 2 | Mr. Lyu Hongbin M.B.A. | CFO & Board Secretary |
| 3 | Ms. Zhiwei Zhang | Deputy GM, VP & Head of Operations |
| 4 | Dr. Qingbei Zeng Ph.D. | Deputy GM, Chief Scientist & Senior VP |
| 5 | Dr. Zhenfan Yang M.D., Ph.D. | Deputy GM & Chief Medical Officer |
| 6 | Ms. Qingyi Wu | Deputy GM & Chief Commercial Officer |
| 7 | Dr. Honchung Tsui | Deputy GM, Senior VP & Head of Medicinal Chemistry Department |
| 8 | Dr. Shih-Ying Chang Ph.D. | Deputy GM, VP and Head of Chemistry, Production & Control Department |
| 9 | Ms. Suqin Chen | Deputy GM & Senior VP of Clinical Operations |
| 10 | Mr. Weijun Qiao | VP & Head of Registration Affairs |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.